Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

Core Laboratories Q4 Adj EPS $0.19, Inline, Sales $128.21M Beat $127.77M Estimate

Author: Benzinga Newsdesk | January 31, 2024 06:23pm
Core Laboratories (NYSE:CLB) reported quarterly earnings of $0.19 per share which met the analyst consensus estimate. This is a 5 percent decrease over earnings of $0.20 per share from the same period last year. The company reported quarterly sales of $128.21 million which beat the analyst consensus estimate of $127.77 million by 0.34 percent. This is a 0.50 percent increase over sales of $127.57 million the same period last year.

Posted In: CLB


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist